Sökning: "Eva-Lotta Glader"
Visar resultat 1 - 5 av 8 avhandlingar innehållade orden Eva-Lotta Glader.
1. Stroke care in Sweden : Hospital care and patient follow-up based on Riks-Stroke, the National Quality Register for Stroke Care
Sammanfattning : .... LÄS MER
2. Rehabilitation after stroke with focus on early supported discharge and post-stroke fatigue
Sammanfattning : Background Stroke is a major cause of disability worldwide. After treatment in a specialized stroke unit, early supported discharge (ESD) followed by home rehabilitation has shown to be an effective way to improve patient outcome and quality of care for persons with mild to moderate stroke. LÄS MER
3. The impact of organizational and temporal factors on acute stroke care in Sweden
Sammanfattning : Background: Acute stroke carries a high risk of morbidity and death, but early treatment can improve outcomes. Intravenous stroke thrombolysis (IVT) is one such treatment, it is however time-sensitive and show better outcomes the sooner it is given. LÄS MER
4. The burden of stroke in Sweden : studies on costs and quality of life based on Riks-Stroke, the Swedish stroke register
Sammanfattning : The costs for stroke management and reduced health related quality of life (QoL) can extend throughout life as mental and physical disabilities are common. The aim of this thesis was to quantify this stroke-related burden with data from Riks-Stroke (RS), the Swedish stroke register. LÄS MER
5. Medication-related problems and psychotropic drug use in vulnerable older populations : a focus on acute hospital admissions and cognitive impairment
Sammanfattning : The ageing process involves several physiological changes that affect both pharmacodynamics and pharmacokinetics and that, in combination with a heavier disease burden and more extensive use of medicines, put older people at higher risk of medication-related problems and associated clinical outcomes. The older population is often treated as a homogenous group, when in fact there are factors that render certain individuals more vulnerable to adverse drug effects and other types of medication-related problems. LÄS MER